Pharvaris NV (PHVS) FinancialsPHVSPharvaris NV

Evaluating the bottom line, Pharvaris N.V. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -70.46%, provide a clear picture of how effectively PHVS converts its operational activities into shareholder value.

In the context of the broader market, PHVS competes directly with industry leaders such as BCRX and VERA. With a market capitalization of $2.18B, it holds a leading position in the sector. When comparing efficiency, PHVS's gross margin of N/A stands against BCRX's 98.24% and VERA's N/A. Such benchmarking helps identify whether Pharvaris N.V. is trading at a premium or discount relative to its financial performance.

Pharvaris has reported consistent net losses, with the latest loss at €47.8 million for Q2 2026, and a negative EPS of -0.70. Despite this, the company has a strong current ratio of 11.94, indicating good liquidity.